Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]      
Revenue $ 869 $ 508 $ 0
Operating expenses:      
Research and development (68,647) (25,499) (10,101)
General and administrative (8,781) (4,464) (3,258)
Total operating expenses (77,428) (29,963) (13,359)
Operating loss (76,559) (29,455) (13,359)
Interest (expense) / income, net (426) 277  
Other income, net 401 216 8
Total other (expense) / income (25) 493 8
Loss before income taxes (76,584) (28,962) (13,351)
Income tax expense (472) (444) (113)
Net loss and comprehensive loss (77,056) (29,406) (13,464)
Net loss attributable to ordinary shareholders $ (77,056) $ (29,406) $ (13,464)
Net loss per share attributable to ordinary shareholders – basic and diluted $ (8.82) $ (170.84) $ (568.87)
Weighted average ordinary shares outstanding – basic and diluted 8,734,109 172,130 23,668